:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Jesse, David, Huber, Cynthia, Friede, Tim
Format:	Preprint
Published:	2024
Subjects:	Methodology
Online Access:	https://arxiv.org/abs/2408.15607
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bayesian analysis of restricted mean survival time adjusted for covariates using pseudo-observations
by: Orsini, Léa, et al.
Published: (2025)

Modeling the restricted mean survival time using pseudo-value random forests
by: Schenk, Alina, et al.
Published: (2024)

Inference of treatment effect and its regional modifiers using restricted mean survival time in multi-regional clinical trials
by: Hua, Kaiyuan, et al.
Published: (2024)

Blinded sample size re-estimation accounting for uncertainty in mid-trial estimation
by: Maeda, Hirotada, et al.
Published: (2026)

Identifying the potential of sample overlap in evidence synthesis of observational studies
by: Zhang, Zhentian, et al.
Published: (2026)

Bayesian random-effects meta-analysis of aggregate data on clinical events
by: Röver, Christian, et al.
Published: (2025)

Methods for non-proportional hazards in clinical trials: A systematic review
by: Bardo, Maximilian, et al.
Published: (2023)

Investigating the heterogeneity of "study twins"
by: Röver, Christian, et al.
Published: (2023)

Meta-analytic-predictive priors based on a single study
by: Röver, Christian, et al.
Published: (2025)

How trace plots help interpret meta-analysis results
by: Röver, Christian, et al.
Published: (2023)

Efficiency of nonparametric superiority tests based on restricted mean survival time versus the log-rank test under proportional hazards
by: Magirr, Dominic, et al.
Published: (2024)

Utilizing subgroup information in random-effects meta-analysis of few studies
by: Huang, Ao, et al.
Published: (2025)

A note on blinded continuous monitoring for continuous outcomes
by: Xu, Long-Hao, et al.
Published: (2025)

Including historical control data in simultaneous inference for pre-clinical multi-arm studies
by: Menssen, Max, et al.
Published: (2026)

Subgroup comparisons within and across studies in meta-analysis
by: Panaro, Renato, et al.
Published: (2025)

Consistent Bayesian meta-analysis on subgroup specific effects and interactions
by: Panaro, Renato, et al.
Published: (2025)

Doubly robust estimators of the restricted mean time in favor estimands in individual- and cluster-randomized trials
by: Fang, Xi, et al.
Published: (2026)

Bayesian generalized method of moments applied to pseudo-observations in survival analysis
by: Orsini, Léa, et al.
Published: (2024)

Assessing covariate-adjusted risk differences in small-sample clinical trials
by: Schnuerch, Martin, et al.
Published: (2026)

A two-step approach for analyzing time to event data under non-proportional hazards
by: Brugger, Jonas, et al.
Published: (2024)

In silico clinical trials in drug development: a systematic review
by: Chen, Bohua, et al.
Published: (2025)

One-sample survival tests in the presence of non-proportional hazards in oncology clinical trials
by: Szurewsky, Chloé, et al.
Published: (2025)

A studentized permutation test for the treatment effect in individual participant data meta-analysis
by: Tran, Phuc Thien, et al.
Published: (2025)

Bayesian joint modelling of longitudinal biomarkers to enable extrapolation of overall survival: an application using larotrectinib trial clinical data
by: Linsell, Louise, et al.
Published: (2025)

Multiple tests for restricted mean time lost with competing risks data
by: Munko, Merle, et al.
Published: (2024)

Doubly protected estimation for survival outcomes utilizing external controls for randomized clinical trials
by: Gao, Chenyin, et al.
Published: (2024)

Restricted mean survival times for comparing grouped survival data: a Bayesian nonparametric approach
by: Riva-Palacio, Alan, et al.
Published: (2024)

Restricted mean time lost for survival and competing risks data using mets in R
by: Scheike, Thomas Harder, et al.
Published: (2026)

Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data
by: Lipkovich, Ilya, et al.
Published: (2023)

A pseudo-outcome-based framework to analyze treatment heterogeneity in survival data using electronic health records
by: Bo, Na, et al.
Published: (2024)

Mathematical programming tools for randomization purposes in small two-arm clinical trials: A case study with real data
by: Vazquez, Alan R., et al.
Published: (2024)

Model‐Based Recursive Partitioning for Discrete Event Times
by: Cynthia Huber, et al.
Published: (2025)

A general Bayesian approach to design adaptive clinical trials with time-to-event outcomes
by: McGree, James M., et al.
Published: (2023)

Adaptive clinical trial design with delayed treatment effects using elicited prior distributions
by: Salsbury, James, et al.
Published: (2025)

Estimands and doubly robust estimation for cluster-randomized trials with survival outcomes
by: Fang, Xi, et al.
Published: (2025)

Chauhan Weighted Trajectory Analysis reduces sample size requirements and expedites time-to-efficacy signals in advanced cancer clinical trials
by: Chauhan, Utkarsh, et al.
Published: (2024)

Estimand framework and intercurrent events handling for clinical trials with time-to-event outcomes
by: Fang, Yixin, et al.
Published: (2025)

Sample size reassessment in Bayesian hybrid clinical trials
by: Ratta, Marco, et al.
Published: (2025)

Q-approximation of operating characteristics of clinical trial designs
by: Gentile, Susanna, et al.
Published: (2026)

Integrating tumor burden with survival outcome for treatment effect evaluation in oncology trials
by: Bhandari, Saurabh, et al.
Published: (2025)